Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma

JOURNAL ARTICLE published 8 April 2021 in New England Journal of Medicine

Authors: Robert Motzer | Boris Alekseev | Sun-Young Rha | Camillo Porta | Masatoshi Eto | Thomas Powles | Viktor Grünwald | Thomas E. Hutson | Evgeny Kopyltsov | María J. Méndez-Vidal | Vadim Kozlov | Anna Alyasova | Sung-Hoo Hong | Anil Kapoor | Teresa Alonso Gordoa | Jaime R. Merchan | Eric Winquist | Pablo Maroto | Jeffrey C. Goh | Miso Kim | Howard Gurney | Vijay Patel | Avivit Peer | Giuseppe Procopio | Toshio Takagi | Bohuslav Melichar | Frederic Rolland | Ugo De Giorgi | Shirley Wong | Jens Bedke | Manuela Schmidinger | Corina E. Dutcus | Alan D. Smith | Lea Dutta | Kalgi Mody | Rodolfo F. Perini | Dongyuan Xing | Toni K. Choueiri